# A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation

> **NCT01937663** · PHASE2 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.**

## Conditions studied

- Chronic Constipation

## Interventions

- **DRUG:** KWA-0711

## Key facts

- **NCT ID:** NCT01937663
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2014-01
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2014-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01937663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01937663, "A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic Constipation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01937663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*